The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CITIUS PHARMACEUTICALS INC | COM NEW | 17322U207 | 26 | 14,600 | SH | SOLE | 0 | 0 | 14,600 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 242 | 610 | SH | SOLE | 0 | 0 | 610 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 256 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 307 | 20,328 | SH | SOLE | 0 | 0 | 20,328 | ||
NVIDIA CORPORATION | COM | 67066G104 | 400 | 749 | SH | SOLE | 0 | 0 | 749 | ||
JOHNSON & JOHNSON | COM | 478160104 | 548 | 3,336 | SH | SOLE | 0 | 0 | 3,336 | ||
ALPHABET INC | CAP STK CL A | 02079K305 | 3,921 | 1,901 | SH | SOLE | 0 | 0 | 1,901 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 4,138 | 2,000 | SH | SOLE | 0 | 0 | 2,000 | ||
VISA INC | COM CL A | 92826C839 | 5,297 | 25,018 | SH | SOLE | 0 | 0 | 25,018 | ||
MICROSOFT CORP | COM | 594918104 | 5,605 | 23,775 | SH | SOLE | 0 | 0 | 23,775 | ||
SPDR DOW JONES INDL AVERAGE | UT SER 1 | 78467X109 | 5,902 | 17,876 | SH | SOLE | 0 | 0 | 17,876 | ||
AMAZON COM INC | COM | 023135106 | 6,634 | 2,144 | SH | SOLE | 0 | 0 | 2,144 | ||
APPLE INC | COM | 037833100 | 6,681 | 54,695 | SH | SOLE | 0 | 0 | 54,695 | ||
ISHARES TR | CORE S&P500 ETF | 464287200 | 35,092 | 88,210 | SH | SOLE | 0 | 0 | 88,210 | ||
FIDELITY COMWLTH TR | NASDAQ COMPSIT | 315912808 | 39,546 | 77,004 | SH | SOLE | 0 | 0 | 77,004 |